- Amply’s Grant Funding Success: Belfast-based Amply secures £1.4M in grants for AI-powered drug discovery, targeting RNAi therapy for leukemia and a nebulized product for MDR-TB.
- Diverse Support and Future Plans: Funding from Innovate UK, Innosuisse, and plans to raise an additional £1.4M in seed funding highlight confidence and growth potential.
- Strategic Backing and Innovation Focus: Supported by Clarendon Fund Managers, Invest NI, British Business Bank, and others, Amply aims to democratize therapeutic discovery with its Drug Discovery Studio.
